Gyre Therapeutics, Inc. Other Nonoperating Income
Gyre Therapeutics, Inc. (GYRE) reported Other Nonoperating Income of $109.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncome · last filed 2024-05-13
- Gyre Therapeutics, Inc. other nonoperating income for the quarter ending 2024-03-31 was $109.00K, a 65.15% increase year-over-year.
- Gyre Therapeutics, Inc. other nonoperating income for the quarter ending 2023-03-31 was $66.00K.
- Gyre Therapeutics, Inc. other nonoperating income for the quarter ending 2021-06-30 was $2.00K, a 86.67% decline year-over-year.
- Gyre Therapeutics, Inc. other nonoperating income for the quarter ending 2021-03-31 was $9.00K, a 98.67% decline year-over-year.
- Gyre Therapeutics, Inc. other nonoperating income for fiscal 2023 was $1.08M, a 25.55% increase from fiscal 2022.
- Gyre Therapeutics, Inc. other nonoperating income for fiscal 2022 was $857.00K.
- Gyre Therapeutics, Inc. other nonoperating income for fiscal 2019 was $7.00K.
| Period end | Other Nonoperating Income 3 month | Other Nonoperating Income 3 month as first filed | Other Nonoperating Income 6 month | Other Nonoperating Income 6 month as first filed | Other Nonoperating Income 9 month | Other Nonoperating Income 12 month |
|---|---|---|---|---|---|---|
| 2024-03-31 | $109.00K 10-Q · filed 2024-05-13 | |||||
| 2023-12-31 | $1.08M 10-K · filed 2024-03-27 | |||||
| 2023-03-31 | $66.00K 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | $857.00K 10-K · filed 2024-03-27 | |||||
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-05 | $11.00K 10-Q · filed 2021-08-05 | ||||
| 2021-03-31 | $9.00K 10-Q · filed 2021-05-06 | |||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $15.00K derived: sum of 2 quarters · filed 2020-11-05 | $679.00K 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | $15.00K 10-Q · filed 2020-08-06 | $679.00K 10-Q · filed 2021-08-05 | $13.00K 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | $679.00K 10-Q · filed 2021-05-06 | $2.00K 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | $7.00K 10-K · filed 2020-02-20 | |||||
| 2019-06-30 | $30.00K 10-Q · filed 2020-08-06 | |||||
| 2015-06-30 | $96.00K 8-K/A · filed 2015-10-23 | |||||
| 2014-12-31 | $541.92K 8-K/A · filed 2015-10-23 | |||||
| 2014-06-30 | $135.00K 8-K/A · filed 2015-10-23 | $263.00K 8-K/A · filed 2015-10-23 | ||||
| 2013-12-31 | $153.61K 8-K/A · filed 2015-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |